3,087
Views
11
CrossRef citations to date
0
Altmetric
Reviews

Impact of Motivational Interviewing on Medication Adherence in Schizophrenia

, RN, BSN
Pages 900-904 | Received 13 Jan 2015, Accepted 01 Jun 2015, Published online: 02 Dec 2015

References

  • Anderson, K. H., Ford, S., Robson, D., Cassis, J., Rodrigues, C., & Gray, R. (2010). An exploratory, randomized controlled trial of adherence therapy for people with schizophrenia. International Journal of Mental Health Nursing, 19, 340–349. doi: 10.1111/j.1447-0349.2010.00681.x
  • Barkhof, E., Meijer, C. J., de Sonneville, L. M., Linszen, D. H., & de Haan, L. (2013). The effect of motivational interviewing on medication adherence and hospitalization rates in non-adherent patients with multi-episode schizophrenia. Schizophrenia Bulletin, 39(6), 1242–1251.
  • Byerly, M. J., Fisher, R., Carmody, T., & Rush, A. J. (2005). A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder. The Journal of Clinical Psychiatry, 66(8), 997–1001.
  • Hegedüs, A., & Kozel, B. (2014). Does adherence therapy improve medication adherence among patients with schizophrenia? A systematic review. International Journal of Mental Health Nursing, 23(6), 490–497. doi: 10.1111/inm.12089
  • Karatay, G., Kublay, G., & Emiroğlu, O. N. (2010). Effect of motivational interviewing on smoking cessation in pregnant women. Journal of Advanced Nursing, 66(6), 1328–1337.
  • Kikkert, M. J., Schene, A. H., Koeter, M. W. J., Robson, D., Born, A., Helm, H., Nose, M., Goss, C., Thornicroft, G., & Gray, R. J. (2006). Medication adherence in schizophrenia: Exploring patients,’ carers’ and professionals’ views. Schizophrenia Bulletin, 32(4), 786–794. doi: 10.1093/schbul/sbl011
  • Lundahl, B., & Burke, B. L. (2009). The effectiveness and applicability of motivational interviewing: A practice-friendly review of four meta-analyses. Journal of Clinical Psychology, 65(11), 1232–1245. doi: 10.1002/jclp.20638
  • Maneesakorn, S., Robson, D., Gournay, K., & Gray, R. (2007). An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand. Journal of Clinical Nursing, 16(7), 1302–1312.
  • McIntosh, A., Conlon, L., Lawrie, S., & Stanfield, A. C. (2006). Compliance therapy for schizophrenia. Cochrane Database of Systematic Reviews, 3, Article No.: CD003442. doi: 10.1002/14651858.CD003442.pub2
  • Miller, W. R., & Rollnick, S. (2009). Ten things that motivational interviewing is not. Behavioural and Cognitive Psychotherapy, 37, 129–140.
  • National Alliance on Mental Illness. (2014). Second generation antipsychotic medication (SGAs): Important side effects. Retrieved from http://www.nami. org/Content/NavigationMenu/Hearts_and_Minds/Second_Generation_Antis- pychotic_Medications.htm
  • Roberts, D. L., & Velligan, D. I. (2011). Medication adherence in schizophrenia. Drug Discovery Today: Therapeutic Strategies, 8(1), 11–15.
  • Schulz, M., Gray, R., Spiekermann, A., Abderhalden, C., Behrens, J., & Driessen, M. (2013). Adherence therapy following an acute episode of schizophrenia: A multi-centre randomized controlled trial. Schizophrenia Research, 146(1), 59–63.
  • Sciacca, K. (2009). Motivational interviewing—MI, glossary, and fact sheet. Retrieved from http://www.motivationalinterview.net/miglossary.pdf
  • Sobell, L. C., & Sobell, M. B. (2008). Motivational interviewing strategies and techniques: Rationales and examples. Retrieved from http://www.nova.edu/gsc/forms/mi_rationale_techniques.pdf
  • Tay, S. C. (2007). Compliance therapy: An intervention to improve inpatients’ attitudes toward treatment. Journal of Psychosocial Nursing, 45(6), 29–36.
  • Vasilaki, E. I., Hosier, S. G., & Cox, W. M. (2006). The efficacy of motivational interviewing as a brief intervention for excessive drinking: A meta-analytic review. Alcohol and Alcoholism, 41(3), 328–335. doi: 10.1093/alcalc/agl016
  • Weiden, P. J., & Olfson, M. (1995). Cost of relapse in schizophrenia. Schizophrenia Bulletin, 21(3), 419–429.
  • Zygmunt, A., Olfson, M., Boyer, C. A., & Mechanic, D. (2002). Interventions to improve medication adherence in schizophrenia. American Journal of Psychiatry, 159(10), 1653–1664.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.